EGFR c.2_60del ;(p.M1_?20)

Variant ID: 7-55086972-ATGCGACCCTCCGGGACGGCCGGGGCAGCGCTCCTGGCGCTGCTGGCTGCGCTCTGCCCG-A

NM_005228.3(EGFR):c.2_60del;(p.M1_?20)

This variant was identified in 2 publications

View GRCh38 version.



Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP

Publications:

Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis.

Faseb Bioadvances
Howell, Mark C MC; Green, Ryan R; Khalil, Roukiah R; Foran, Elspeth E; Quarni, Waise W; Nair, Rajesh R; Stevens, Stanley S; Grinchuk, Aleksandr A; Hanna, Andrew A; Mohapatra, Shyam S; Mohapatra, Subhra S
Publication Date: 2020-02

Variant appearance in text: EGFR: 1_471del
PubMed Link: 32123859
Variant Present in the following documents:
  • Main text
View BVdb publication page


LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition.

British Journal Of Cancer
Mahoney, C L CL; Choudhury, B B; Davies, H H; Edkins, S S; Greenman, C C; Haaften, G van Gv; Mironenko, T T; Santarius, T T; Stevens, C C; Stratton, M R MR; Futreal, P A PA
Publication Date: 2009-01-27

Variant appearance in text: EGFR: 1_457del
PubMed Link: 19165201
Variant Present in the following documents:
  • Main text
  • 6604886a.pdf
View BVdb publication page